6] Wu HJ, Wu HT, Weng DH, et al. Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms [J]. Zhonghua Fu Chan Ke Za Zhi，2007,42(9):612-616.
[7] Takai N, Narahara H. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis [J]. Curr Med Chem，2007，14(24):2548-2553.
[8] Puiffe ML, Le Page C, Filali-Mouhim A, et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer [J]. Neoplasia，2007，9(10):820-829.
[9] Lou JY, Peng ZL, Zheng Y, et al. Research on human ovarian cancer cell MDR1 gene silenced by siRNA [J]. Sichuan Da Xue Xue Bao Yi Xue Ban,2007,38(5):753-755.
[10] Saldivar JS, Wu X, Follen M, et al. Nucleotide excision repair pathway review I: implications in ovarian cancer and platinum sensitivity [J]. Gynecol Oncol,2007,107(Suppl 1):S56-71.
[11] Ludwig AH, Bujko M, Bidzinski M, et al. CHFR gene is neither mutated nor hypermethylated in ovarian cancer [J]. Cancer Detect Prev,2007,31(3):257-261.
[12] Milczek T, Klasa-Mazurkiewicz D, Emerich J, et al. DNA ploidy and results of first line chemotherapy in ovarian cancer patients [J]. Ginekol Pol,2006 ,77(8):589-596.
[13] Morari EC, Lima AB, Bufalo NE, et al. Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients [J]. J Cancer Res Clin Oncol,2006,132(8):521-528.
[14] Park JT, Li M, Nakayama K, et al. Notch3 gene amplification in ovarian cancer [J]. Cancer Res,2006,66(12):6312-6318.
[15] Indraccolo S, Tisato V, Agata S, et al. Establishment and characterization of xenografts and cancer cell cultures derived from BRCA1-/-epithelial ovarian cancers [J]. Eur J Cancer,2006, 42(10):1475-1483.
[16] Zhang L, Huang J, Yang N, et a
上一页 [1] [2] [3] [4] [5] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 妇产科论文 >> 正文